Related Experiment Videos

Clustering of metabolic factors among the patients with essential hypertension

Md Abu Siddique1, Md Ashraf Uddin Sultan, K M H S Sirajul Haque

  • 1Department of Cardiology, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka, Bangladesh. drabusiddique@yahoo.com

Bangladesh Medical Research Council Bulletin
|May 30, 2009
PubMed

Insights

Metabolic syndrome is common in hypertensive patients, particularly women. This study highlights the high prevalence of metabolic syndrome components in this patient group.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Metabolic syndrome is a cluster of conditions that increase the risk of heart disease, stroke, and type 2 diabetes.
  • Hypertension is a major risk factor for metabolic syndrome.
  • Understanding the prevalence of metabolic syndrome in hypertensive patients is crucial for targeted interventions.

Purpose of the Study:

  • To determine the prevalence of metabolic syndrome and its components in a clinic-based population of hypertensive patients.
  • To analyze the differences in prevalence between men and women.

Main Methods:

  • A cross-sectional study was conducted on 1,517 hypertensive patients.
  • Data on hypertension, high triglyceride, low HDL cholesterol, high blood glucose, and large waist circumference were collected.
  • Prevalence of individual components and combinations of three traits were calculated.

Main Results:

  • The overall prevalence of metabolic syndrome was 1.1% in men and 12.8% in women.
  • Specific combinations of traits were significantly more prevalent in women, such as hypertension with low HDL and large waist (70.6%).
  • Hypertension with high triglyceride and large waist was also notably higher in women (39.3%).

Conclusions:

  • Metabolic syndrome is highly prevalent among hypertensive patients, with a disproportionately higher burden in women.
  • The findings underscore the need for screening and management of metabolic syndrome in hypertensive individuals, especially women.
  • Targeted public health strategies are recommended to address this significant health issue.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...